Sanofi claims high-ris­es neigh­bor­ing its Toron­to fa­cil­i­ty would pose 'na­tion­al se­cu­ri­ty' threat

Sanofi isn’t so hap­py with one of its neigh­bors. The French phar­ma gi­ant is go­ing to bat­tle against a Cana­di­an de­vel­op­er’s pro­pos­al to build two, 30-plus-sto­ry res­i­den­tial tow­ers less than half a mile away from its Toron­to fa­cil­i­ty, cit­ing “na­tion­al se­cu­ri­ty con­cerns.”

The news comes just un­der a year af­ter Sanofi an­nounced it’s dump­ing more than $676 mil­lion in­to a new vac­cine man­u­fac­tur­ing fa­cil­i­ty at the Toron­to site, which will be re­spon­si­ble for ad­di­tion­al anti­gen and fill­ing ca­pac­i­ty for its Flu­zone high-dose quadri­va­lent vac­cine. The new fa­cil­i­ty should be up and run­ning in 2026, the com­pa­ny said back in March.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER